MedPage  |  May 15, 2017

Eric Lindblom of Georgetown University’s O’Neill Institute for National and Global Health Law said the FDA should create a fast-track regulatory review which would allow both small and large manufacturers of e-cigarettes to keep their products on the market and allow them to make reduced-risk claims if they agree to certain conditions.

He noted that in spite of the fact that e-cigarettes have been largely unregulated and that vaping is often allowed in areas where smoking is not, most smokers are not switching to e-cigarettes.

“One missing ingredient is that there hasn’t been the opportunity to make reduced harm claims and make those directly to smokers in accurate and persuasive ways,” he said.

Read more here.